Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Solid Biosciences (SLDB) Restructuring Costs (2020 - 2023)

Solid Biosciences (SLDB) has disclosed Restructuring Costs for 3 consecutive years, with -$63000.0 as the latest value for Q2 2023.

  • Quarterly Restructuring Costs fell 104.14% to -$63000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Dec 2023, down 22.05% year-over-year, with the annual reading at -$63000.0 for FY2023, 100.88% down from the prior year.
  • Restructuring Costs hit -$63000.0 in Q2 2023 for Solid Biosciences, down from $5.7 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $5.7 million in Q4 2022 to a low of -$63000.0 in Q2 2023.
  • Historically, Restructuring Costs has averaged $2.3 million across 3 years, with a median of $1.7 million in 2020.
  • Biggest YoY gain for Restructuring Costs was 104.14% in 2023; the steepest drop was 104.14% in 2023.
  • Year by year, Restructuring Costs stood at $1.9 million in 2020, then soared by 191.05% to $5.7 million in 2022, then tumbled by 101.11% to -$63000.0 in 2023.
  • Business Quant data shows Restructuring Costs for SLDB at -$63000.0 in Q2 2023, $5.7 million in Q4 2022, and $1.5 million in Q2 2022.